Xiaoxue Zhu
- Hepatology top 10%
- Hepatitis C virus research 11
-
- Diabetes Treatment and Management 9
-
- Biosimilars and Bioanalytical Methods 9
-
- Chronic Lymphocytic Leukemia Research 5
-
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 7
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Yanhua DingCuiyun LiHong ZhangJingrui LiuXiaojiao LiMin WuJunqi NiuHong Chen
- Journals
- Journal of Clinical Oncology (1 paper)Clinical Infectious Diseases (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoxue Zhu
57 papers receiving 465 citations
Peers
Comparison fields: 5 of 101
- Hepatology 98
- Endocrinology, Diabetes and Metabolism 74
- Immunology 84
- Genetics 36
- Epidemiology 114
Countries citing papers authored by Xiaoxue Zhu
This map shows the geographic impact of Xiaoxue Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxue Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxue Zhu more than expected).
Fields of papers citing papers by Xiaoxue Zhu
This network shows the impact of papers produced by Xiaoxue Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxue Zhu. The network helps show where Xiaoxue Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoxue Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 5 | |
| 18 | 2019 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2018 | 15 |
About Xiaoxue Zhu
Xiaoxue Zhu is a scholar working on Hepatology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 61 papers that have together received 471 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (9 papers), Biosimilars and Bioanalytical Methods (9 papers), Diabetes Treatment and Management (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HIV/AIDS drug development and treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Hepatology (98 citations), Endocrinology, Diabetes and Metabolism (74 citations) and Immunology (84 citations). Xiaoxue Zhu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yanhua Ding, Cuiyun Li, Hong Zhang, Jingrui Liu, Xiaojiao Li, Min Wu, Junqi Niu, Hong Chen, Min Wu and Xiaojiao Li. Their work appears in journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.